Achaogen is a biopharmaceutical company engaged in discovering, developing, and commercializing antibacterial treatments against multi-drug resistant (MDR) gram-negative infections. The company develops plazomicin for the treatment of serious bacterial infections, including complicated urinary tract infection (cUTI), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. The company also develops antibacterial candidate, C-Scape, an orally-administered combination of ceftibuten and clavulanate for oral treatment for patients with cUTI, and acute pyelonephritis, caused by expanded spectrum beta-lactamases-producing Enterobacteriaceae.

American International Group is a holding company. Through its subsidiaries, the company provides a range of property casualty insurance, life insurance, retirement solutions, and other financial services. The company's businesses include General Insurance, which provides insurance products and services for commercial and personal insurance customers; Life and Retirement, which brings together a portfolio of life insurance, retirement and institutional products provided through a multichannel distribution network; and Other Operations, which include Blackboard U.S. Holdings, Inc., a subsidiary focused on delivering commercial insurance solutions using digital technology, data analytics and automation.

CommScope Holding is a provider of infrastructure solutions for communication networks. The company's solutions and services for wired and wireless networks enable high-bandwidth data, video and voice applications. The company's operating segments are: CommScope Connectivity Solutions (CCS) and CommScope Mobility Solutions (CMS). The CCS segment is engaged in providing fiber optic and copper connectivity solutions for use in data centers and business enterprise, telecommunications, cable television and residential broadband networks. The CMS segment is engaged in providing infrastructure for wireless networks.

CVS Health is a health company. The company's segments are: Pharmacy Services, which provides a range of pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; Retail/Long-Term Care (LTC), which sells prescription drugs and general merchandise, including over-the-counter drugs, provides health care services through its MinuteClinic? walk-in medical clinics and conducts LTC pharmacy operations; and Health Care Benefits, which provides a range of voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans.

Fluidigm creates, manufactures, and markets a range of products and services, including instruments, reagents and software that are used by researchers worldwide. The company markets technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, polymerase chain reaction, Library Prep, Single Cell Genomics, and consumables, including integrated fluidic circuits, assays, and reagents. The company's product offerings include: Mass Cytometry, Microfluidics and Single Cell Microfluidics.

Kemper is an insurance holding company. Through its subsidiaries, the company provides automobile, homeowners, life, health, and other insurance products to individuals and businesses. The company conducts its operations through three operating segments: Specialty Property and Casualty Insurance, which provides personal and commercial automobile insurance to consumers who have had difficulty obtaining standard or preferred risk insurance; Preferred Property and Casualty Insurance, which sells preferred automobile insurance, homeowners insurance and other personal insurance; and Life and Health Insurance, which provides individual life and supplemental accident and health insurance products.

MongoDB operates as a general purpose database platform. The company's primary offerings are: MongoDB Enterprise Advanced, which includes the company's proprietary commercial database server, enterprise management capabilities, its graphical user interface, analytics integrations, technical support and a commercial license to its platform; MongoDB Atlas, which provides customers with automated provisioning and healing, system monitoring, managed backup and restore, default security and other features; and Community Server, which is a free-to-download version of the company's database that does not include all of the features of its commercial platform. The company also provides consulting and training to its customers.

Nuvasive is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for spine surgery. The company's principal product offering includes a minimally disruptive surgical platform, Maximum Access Surgery. The platform includes the company's proprietary software-driven nerve detection and avoidance systems, and Intraoperative Monitoring services and support; MaXcess, an integrated split-blade retractor system; and implants and biologics. The company's spine surgery product line offerings, which include products for the thoracolumbar and the cervical spine, are used to enable surgeon access to the spine to perform restorative and fusion procedures.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Orthofix International is a medical device company focused on musculoskeletal healing products and services. Co.'s business units are: BioStim, which manufactures, distributes, and provides support services for bone growth stimulation devices; Extremity Fixation, which provides products and solutions that allow physicians to treat a range of orthopedic conditions unrelated to the spine; Spine Fixation, which focuses on the design, development and marketing of a portfolio of implant products used in surgical procedures of the spine; and Biologics, which provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions.

Second Sight Medical Products develops, manufactures and markets implantable visual prosthetics that deliver artificial vision to blind individuals. The company's product, the Argus ? II Retinal Prosthesis System (Argus II), treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. RP is a hereditary disease that causes a progressive degeneration of the light-sensitive cells of the retina, which leads to visual impairment and blindness. The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. It does not restore normal vision and it does not slow or reverse the progression of the disease.

Tesla designs, develops, manufactures, sells and leases electric vehicles and energy generation and storage systems, and provides services related to its products. The company operates as two reportable segments: automotive, which includes the design, development, manufacturing, sales, and leasing of electric vehicles as well as sales of automotive regulatory credits; and energy generation and storage, which includes the design, manufacture, installation, sales, and leasing of solar energy generation and energy storage products, services related to such products, and sales of solar energy system incentives.